Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial
Alexis Jones, Patrick Muller, Caroline Dore, Felicia Ikeji, Emilia Caverly, Kashfia Chowdhury, David Isenberg, Caroline Gordon, Michael Ehrenstein
Research output: Contribution to journal › Article › peer-review
10Citations
(Scopus)
197Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial'. Together they form a unique fingerprint.